The aim of this study was to investigate the prevalences of plasmid-mediated AmpC -lactamases (PABLs) in isolates of Escherichia coli and Klebsiella spp. from a university hospital in China. A total of 1,935 consecutive nonrepeat clinical isolates of Escherichia coli, Klebsiella pneumoniae, and Klebsiella oxytoca were collected between January 2003 and July 2005. The isolates with cefoxitin zone diameters less than 18 mm (screen positive) were selected for PCR of the bla AmpC genes and sequencing. Fifty-four (2.79%) isolates harbored PABLs, as demonstrated by PCR and isoelectric focusing. Sequence analysis revealed the presence of bla DHA-1 and bla CMY-2 genes. The Southern blot hybridization studies confirmed that bla CMY-2 and bla DHA-1 were located on plasmids. Based on species, PABLs were detected in 4.29% (29 isolates of DHA-1 and 1 isolate of CMY-2) of K. pneumoniae, 1.91% (11 isolates of DHA-1 and 12 isolates of CMY-2) of E. coli, and 3.03% (1 isolate of DHA-1) of K. oxytoca isolates. In contrast to our anticipation, the occurrence rate of DHA-1-producing K. pneumonia significantly decreased (P < 0.01), from 7.54% in 2003 to 2.72% in 2004. The results of random amplified polymorphic DNA analysis indicate that the prevalences of DHA-1-producing K. pneumoniae and CMY-2-producing E. coli strains were not due to epidemic strains. In conclusion, DHA-1 was the most prevalent acquired AmpC beta-lactamase in this collection of isolates from a medical center in China, and DHA-1-producing K. pneumoniae was the most prevalent bacterium harboring a PABL. To the best of our knowledge, this is the first report of CMY-2-type AmpC -lactamases in the Chinese mainland.Plasmid-mediated AmpC -lactamases (PABLs) are derived from chromosomal ampC genes of the family Enterobacteriaceae, such as those of Citrobacter freundii, Enterobacter cloacae, and Aeromonas species.PABLs have been reported to occur in the United States, Korea, Japan, etc. (4,14,24), but there are seldom data indicating PABLs in the Chinese mainland (28,29). The aims of this study were to establish the prevalence rate of this resistance mechanism in isolates of Klebsiella pneumoniae, Klebsiella oxytoca, and Escherichia coli from a university hospital in Shanghai, China. The first identification of the CMY-2 AmpC -lactamase in the Chinese mainland is also described. Antimicrobial susceptibility testing and screening of -lactamases. Isolates were tested for susceptibility by the standard disk diffusion method, and the results were interpreted according to the guidelines of the CLSI (formerly NCCLS). Isolates with cefoxitin zone diameters less than 18 mm (4) were considered positive for the AmpC -lactamase screening test and were selected for MIC, isoelectric focusing (IEF), PCR, and sequencing analyses. The MICs and the presence of extended-spectrum -lactamases (ESBLs) were determined by using the ESBL confirmation panel (Dade-Behring, Sacramento, CA). The presence of ESBLs was also investigated by the CLSI-recommended disk screening and confirmatory tes...